EmployblEmploybl logo
employbl
Interius BioTherapeutics logo

Interius BioTherapeutics Funding & Investors

Philadelphia, PA

Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.

interiusbio.com

Total Amount Raised: $154,383,872

Interius BioTherapeutics Funding Rounds

  • Series B

    $51,432,536

  • Debt Financing

    $21,451,331

  • Series A

    $76,000,000

    Series A Investors

    Cormorant Asset Management
    Fairmount Funds Management
    Longwood Fund
    Tellus BioVentures
    Bain Capital Life Sciences
    Knollwood Investment Advisory
    Pfizer Venture Investments
    Logos Capital
    RA Capital Management
    Osage University Partners II
    BrightEdge Fund
    Quan Capital
    The Mark Foundation for Cancer Research US
    Agent Capital
    Penn Medicine Co-Investment Program
    University of Pennsylvania (Penn)

  • Seed

    $5,500,000

    Seed Investors

    Tellus BioVentures
    Penn Medicine Co-Investment Program
    Agent Capital
    Bruce Peacock
    The Mark Foundation for Cancer Research US
Funding info provided by Diffbot.